# BPC-157 Peptide: A Patient Guide Ahead of the July 2026 PCAC Review

**By TelosRX Editorial Team** · 2026-04-14

**BPC-157 is a research peptide studied for tissue support that is available through compounding pharmacies when clinically appropriate.** Patients can request a telehealth evaluation through the [TelosRX Telehealth Portal](https://telosrx.com).

## What Is BPC-157?

BPC-157 is a 15-amino-acid peptide derived from a sequence found in gastric juice. It is studied in preclinical research.

It is not an FDA-approved drug. It is available through compounding pharmacies under valid prescription.

## Common Discussion Points

Patients often raise BPC-157 during evaluations for:

-   Soft tissue recovery research interest
-   Gastrointestinal support exploration
-   Connective tissue health discussion
-   Post-exercise recovery research

A licensed provider determines clinical appropriateness individually.

## Pre-PCAC July 2026 Regulatory Context

The Pharmacy Compounding Advisory Committee (PCAC) is scheduled to review peptide compounding categories in July 2026. BPC-157 is among the compounds under regulatory consideration.

Patients interested in compounded BPC-157 should consult a licensed provider while access remains available.

## How TelosRX Handles BPC-157

TelosRX is an online-first telehealth service. Patient evaluation is asynchronous, and compounded medications are prepared through our licensed pharmacy partner.

-   **Step 1:** Complete an asynchronous telehealth intake at [TelosRX](https://telosrx.com).
-   **Step 2:** A licensed provider reviews your intake.
-   **Step 3:** If clinically appropriate, the provider issues a prescription.
-   **Step 4:** Your compounded preparation ships discreetly to your door.

Ready to see whether compounded BPC-157 is appropriate for you? A licensed provider can review your history through a short online visit.

[Start your online visit](https://start.telosrx.com/start-online-visit/peptides)

## Important Compliance Information

BPC-157 is not FDA-approved. Compounded preparations are prepared under federal compounding regulations.

Prescriptions require evaluation by a licensed healthcare provider. Approval is not guaranteed. Individual results vary.

TelosRX operates under LegitScript-certified telehealth standards.

Start your private evaluation at [TelosRX](https://telosrx.com).

**Tags:** BPC-157, peptide, research peptide, telehealth, tissue support

---

> Source: [Telos RX](https://www.telosrx.com/blogs/peptides/bpc-157-peptide-patient-guide-pcac-2026)